Small Molecule Videos

31. Mastering Ophthalmic Drug Formulation And Testing 1/15/2026

    In this on-demand webinar, our manufacturing experts provide insights into the growing ophthalmic market and how to optimize your drug development research outcomes.

32. T3P – A Green Solution For Peptide Coupling, Water Removal Reactions 1/13/2026

    The session focuses on the use of T3P (propanephosphonic acid anhydride) in amidation and peptide coupling reactions, including both liquid-phase and solid-phase peptide synthesis.

33. Reimagining API Manufacturing – How To Achieve Smarter, Scalable Flow Chemistry 1/13/2026

    Designed for scientists and engineers evaluating advanced reactors, this recording delivers practical insights and real-world examples to support safer, more efficient, and adaptable flow chemistry.

34. ROIS: Your Contract Manufacturing Partner 12/29/2025

    Our injectable and solid dosage form products are manufactured at state-of-the-art facilities located in the Madrid metropolitan area of Spain.

35. Zhunan Facility Site VR Tour 12/23/2025

    Bora’s 36,000-square-meter Zhunan, Taiwan facility delivers flexible, high-quality cGMP oral solid dose manufacturing with access to major markets including North America and the EU.

36. The Impact Of PEGs In The Small Molecule API Market 12/22/2025

    Explore how PEG selection shapes drug development success by understanding the benefits of expert CDMO partnerships that deliver custom solutions to enhance your small molecule program.

37. Fostering Effective Sponsor–CDMO Collaboration (Trust vs. Oversight) 12/1/2025

    This segment of the Outsourced Pharma Live event, “Small Molecule Outsourcing: Getting Timelines, Tech Transfer and Analytics Right,” addresses how to balance trusting a CDMO as a subject-matter expert with maintaining sufficient oversight through clear KPIs, targeted on-site presence at critical milestones, and a partnership mindset where both sides work to enable each other’s success and demonstrate ongoing trustworthiness.

38. Avoiding And Mitigating Delays In Outsourced Projects 12/1/2025

    This segment of the Outsourced Pharma Live event, “Small Molecule Outsourcing: Getting Timelines, Tech Transfer and Analytics Right,” examines the most common causes of timeline delays in outsourced small molecule development—such as tech transfer challenges, assay development gaps, lean SME resourcing, supply chain constraints, and quality events—and offers practical strategies like contractual detail, contingencies, on-site presence, schedule buffers, and understanding CDMO internal turnaround times.

39. Selecting The Right CDMO Partner For Small Molecule Development 12/1/2025

    This segment of the Outsourced Pharma Live event, Small Molecule Outsourcing: Getting Timelines, Tech Transfer and Analytics Right, explores how small and emerging biopharma companies should prioritize criteria when selecting a CDMO for small molecule projects, including fit-for-purpose equipment, scale range, regulatory inspection history, nimbleness, and experience in target regulatory regions.

40. Key Elements Of Effective Tech Transfer Management 12/1/2025

    This segment of the Outsourced Pharma Live event, “Small Molecule Outsourcing: Getting Timelines, Tech Transfer and Analytics Right,” focuses on the key elements of a successful tech transfer for small molecule processes, emphasizing realistic expectations on duration, leveraging CDMO chemistry expertise to refine rather than simply copy the process, and treating the CDMO as an extension of the sponsor’s own team focused on long-term product quality. Featuring panelist Natalie Farris, Executive CMC Consultant at Naltou Pharma CMC Consulting, LLC.